BioNTech SE Sponsored ADR (BNTX) vs Genmab A/S Sponsored ADR (GMAB)
- BioNTech SE Sponsored ADR BNTX 87.57 −2.92%
- Genmab A/S Sponsored ADR GMAB 37.00 −2.17%
BioNTech SE Sponsored ADR and Genmab A/S Sponsored ADR are both Biotechnology companies. BioNTech SE Sponsored ADR and Genmab A/S Sponsored ADR are of similar size ($22.7B and $22.6B). BioNTech SE Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Genmab A/S Sponsored ADR trades at 29.1×. Genmab A/S Sponsored ADR grew revenue faster over the last twelve months: 22.3% against −3.33%. Genmab A/S Sponsored ADR has the higher net margin (19.1% vs −65.8%) and the higher return on invested capital (6.99% vs −38.4%). Across the 19 metrics below, Genmab A/S Sponsored ADR leads on 12 and BioNTech SE Sponsored ADR on 7.
Valuation
Profitability
| Metric | BNTX | GMAB | Biotechnology median |
|---|---|---|---|
| Gross margin | 75.24% | 93.03% | 65.16% |
| Operating margin | (77.94%) | 25.95% | 0.00% |
| Net margin | (65.75%) | 19.08% | 0.00% |
| Free cash flow margin | 16.58% | (153.64%) | 0.00% |
| Return on equity | (9.53%) | 14.00% | (56.36%) |
| Return on assets | (8.24%) | 8.30% | (48.04%) |
| Return on invested capital | (38.39%) | 6.99% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack